Uncommon mutation types of Epidermal Growth Factor Receptor (EGFR) and tyrosine kinase inhibitor response in non-small cell lung carcinoma

被引：0
|
作者：
Wong, Maria P.
Lee, Victor H. F.
Yeung, Rebecca M. W.
Tin, Vicky P. C.
Choy, Kit Chi
Liu, Jing
机构：
来源：
CLINICAL CANCER RESEARCH | 2012年 / 18卷 / 10期
关键词：
D O I：
10.1158/1078-0432.MECHRES-A25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A25
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients
    Chen, Kaiyan
    Yu, Xiaoqing
    Wang, Haiyang
    Huang, Zhiyu
    Xu, Yanjun
    Gong, Lei
    Fan, Yun
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (06) : 1179 - 1187
  • [2] Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients
    Kaiyan Chen
    Xiaoqing Yu
    Haiyang Wang
    Zhiyu Huang
    Yanjun Xu
    Lei Gong
    Yun Fan
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 80 : 1179 - 1187
  • [3] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Non-Small Cell Lung Cancer With Uncommon Mutations
    Kanazu, Masaki
    Naoki, Yoko
    Shiroyama, Takayuki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Omachi, Naoki
    Okishio, Kyoichi
    Suzuki, Hidekazu
    Okamoto, Norio
    Morishita, Naoko
    Hirashima, Tomonori
    Atagi, Shinji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [4] Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients
    Chen, K.
    Yu, X.
    Wang, H.
    Huang, Z.
    Xu, Y.
    Gong, L.
    Fan, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2131 - S2131
  • [5] Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
    Choi, Yong Won
    Choi, Jin-Hyuk
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 422 - 428
  • [6] Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Lee, Jae Cheol
    Jang, Seung Hun
    Lee, Kye Young
    Kim, Young-Chul
    [J]. CANCER RESEARCH AND TREATMENT, 2013, 45 (02): : 79 - 85
  • [7] Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib
    Masood, Ashiq
    Kancha, Rama Krishna
    Subramanian, Janakiraman
    [J]. SEMINARS IN ONCOLOGY, 2019, 46 (03) : 271 - 283
  • [8] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [9] Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance
    Massarelli, Erminia
    Johnson, Faye M.
    Erickson, Heidi S.
    Wistuba, Ignacio I.
    Papadimitrakopoulou, Vassiliki
    [J]. LUNG CANCER, 2013, 80 (03) : 235 - 241
  • [10] TRANSAMINITIS INDUCED BY EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR PREDICTS FOR FAVOURABLE OUTCOME IN EGFR MUTATION POSITIVE NON-SMALL CELL LUNG CANCER
    Ang, John Kay Hooi
    Jain, Amit
    Chan, Kian Sing
    Takano, Angela
    Lim, Tony Kiat Hon
    Ng, Quan-Sing
    Ang, Mei-Kim
    Oon, Lynette Lin Ean
    Lim, Wan-Teck
    Tan, Eng-Huat
    Tan, Daniel Shao Weng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S608 - S609
12345